Frequently Asked Questions How quickly will I lose weight
The FDA is in a public comment period - closing June 29, 2026 - on a proposal to formally exclude semaglutide and tirzepatide from the 503B Bulk Drug Substances List, a move that would permanently close large-scale compounding pathways for these active ingredients even in a future shortage
These before and after pictures show a range of them, with great results for various patients to date
Wang D, Wei G, Ma J, Cheng S, Jia L, Song X, et al
This research peptide blend combines CJC-1295 (No DAC), a growth hormonereleasing hormone (GHRH) analog, with Ipamorelin, a selective ghrelin receptor agonist
ColonBroom GLP-1 Booster is not a pharmaceutical GLP-1 agonist like semaglutide or liraglutide